53 completed, 38 unknown, 21 recruiting, 11 terminated. 34 Not applicable, 29 Phase 2, 14 Phase 1, 13 Phase 3, 1 Early Phase 1.
Follow The Christie NHS Foundation Trust: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC Bexmarilimab 1mg/kg and nivolumab 1mg/kg, Bexmarilimab 3mg/kg and nivolumab 1mg/kg, Recommended Phase II Dose - Melanoma (Skin Cancer), Non Small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Institute of Cancer Research, United Kingdom | 62 | 2026-08-28 | 2026-09-08 |
| Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy Photobiomodulation - Radio Dermatitis, Mucositis Oral | Not applicable | Not yet recruiting | The Christie NHS Foundation Trust | 248 | 2026-06-01 | 2026-03-19 |
| GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia Cord blood transplantation + conditioning + granulocytes of variable days according to study design - Acute Myeloid Leukemia, Stem Cell Transplantation | Phase 1 / Phase 2 | Not yet recruiting | University of Manchester | 50 | 2026-02-09 | 2026-03-11 |
| DENTOFACIAL-PBT Stage 2 - Feasibility Study Orthopantomogram (or a set of Lateral Oblique Radiographs) - Head and Neck Cancer, Radiotherapy Side Effect | Enrolling by invitation | Manchester University NHS Foundation Trust | 255 | 2026-01-16 | 2026-01-26 | |
| Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma Sample analysis only - Melanoma (Skin Cancer) | Not yet recruiting | The Christie NHS Foundation Trust | 20 | 2026-01-01 | 2025-12-19 | |
| A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer. radiotherapy, BCG - High-Risk Non-Muscle Invasive Bladder Cancer | Phase 3 | Not yet recruiting | The Christie NHS Foundation Trust | 328 | 2025-12-01 | 2025-12-05 |
| To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway Radiotherapy to the spine in a single appointment - Metastatic Spinal Cord Compression | Not applicable | Recruiting | The Christie NHS Foundation Trust | 72 | 2025-11-04 | 2025-12-02 |
| A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION) Abdominal Cancer, Lung Cancer | Recruiting | The Christie NHS Foundation Trust | 60 | 2025-08-29 | 2025-09-05 | |
| Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung Lung Cancer (NSCLC), Lung Cancer (SCLC) | Active not recruiting | The Christie NHS Foundation Trust | 80 | 2025-07-03 | 2025-10-01 | |
| Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal Neuroblastoma Proton Beam Therapy - Abdominal Neuroblastoma | Not applicable | Not yet recruiting | The Christie NHS Foundation Trust | 100 | 2025-03-01 | 2025-02-03 |
| Preoperative Preradiotherapy TTFields TTFields - Glioblastoma | Not applicable | Recruiting | The Christie NHS Foundation Trust | 42 | 2024-12-19 | 2026-05-08 |
| Chronic Radiation Induced Bowel Toxicity Study Procedure - blood, urine and stool sample collection - Prostate Cancer | Recruiting | The Christie NHS Foundation Trust | 50 | 2024-11-19 | 2024-12-20 | |
| Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma Proton Beam Therapy - Parotid Cancer | Not applicable | Not yet recruiting | The Christie NHS Foundation Trust | 97 | 2024-11-01 | 2024-08-21 |
| Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma Proton Beam Therapy, Concurrent oral capecitabine chemotherapy, Cisplatin & Gemcitabine intravenous chemotherapy - Cholangiocarcinoma | Not applicable | Not yet recruiting | The Christie NHS Foundation Trust | 30 | 2024-11-01 | 2024-08-21 |
| Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy Nasopharyngeal Carcinoma, Head and Neck Cancer | Unknown | The Christie NHS Foundation Trust | 10 | 2024-08-30 | 2024-06-28 | |
| Enabling Genomic Testing in Cancer of Unknown Primary Gene panel array, Blood Sample Collection - Cancer of Unknown Primary, Neoplasm, Unknown Primary | Recruiting | The Christie NHS Foundation Trust | 100 | 2024-08-15 | 2026-03-25 | |
| Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy Adaptive Therapy, Standard of Care - Melanoma | Phase 2 | Not yet recruiting | The Christie NHS Foundation Trust | 40 | 2024-06-01 | 2024-06-24 |
| PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma Patient Interview - Multiple Myeloma | Completed | The Christie NHS Foundation Trust | 9 | 2024-04-05 | 2026-05-08 | |
| The CASCADE Project Education, training and assessment intervention - Cancer | Unknown | The Christie NHS Foundation Trust | 1400 | 2024-03-01 | 2024-02-21 | |
| Molecular Characterisation of Appendiceal Cancer Retrospective tissue sample analysis - Appendiceal Cancer | Recruiting | The Christie NHS Foundation Trust | 100 | 2024-02-04 | 2025-01-01 |
Showing 20 of 145. Sign in to see all of them.
Neoplasms (29) · Lung Neoplasms (15) · Carcinoma, Non-Small-Cell Lung (10) · Melanoma (10) · Breast Neoplasms (8) · Esophageal Neoplasms (7) · Prostatic Neoplasms (7) · Head and Neck Neoplasms (6) · Ovarian Neoplasms (5) · Sarcoma (5) · Uterine Cervical Neoplasms (5) · Colorectal Neoplasms (4) · Hodgkin Disease (4) · Lymphoma (4) · Neoplasm Metastasis (4)
Cisplatin (6) · Radiotherapy (5) · Biopsy (4) · Blood Specimen Collection (4) · Cyclophosphamide (4) · Proton Therapy (4) · Fluorouracil (3) · Interleukin-2 (3) · Surveys and Questionnaires (3) · fludarabine (3) · AZD 6244 (2) · Aspirin (2) · Carboplatin (2) · Cetuximab (2) · Gemcitabine (2)
United Kingdom (127) · France (4) · Netherlands (4) · Germany (3) · Italy (3) · Belgium (2) · Denmark (2) · Spain (2) · Sweden (2) · Australia (1) · Austria (1) · Canada (1) · Jordan (1) · Switzerland (1) · United States (1)
Nick Thatcher, PhD, FRCP (3) · Sally Taylor, PhD (3) · Anne Armstrong (2) · Catherine West (2) · Omer Aziz (2) · Adrian Bloor (1) · Alastair Greystoke (1) · Alison Tree, FRCR (1) · Ananya Choudhury (1) · Ananya Choudhury, MA, PhD (1) · Ananya Choudhury, PhD, FRCR, MRCP, MA, MB BChir, (1) · Ananya Choudhury, Phd (1) · Andrew Davies (1) · Andrew G Renehan (1) · Andrew G Renehan, PhD (1)
PMID 14551293, PMID 19782876, PMID 21246515, PMID 21353720, PMID 22014897, PMID 23433435, PMID 24297953, PMID 25721307, PMID 25901426, PMID 26466809, PMID 26817643, PMID 28362511, PMID 28642008, PMID 29313180, PMID 29343167, PMID 29526341, PMID 29602860, PMID 29992040, PMID 30520977, PMID 30920878, PMID 31020334, PMID 31112475, PMID 31932108, PMID 31935289, PMID 32029495, PMID 32552763, PMID 32900761, PMID 32967864, PMID 33014774, PMID 33210382, PMID 33515503, PMID 33561018, PMID 33723969, PMID 33748440, PMID 33798493, PMID 34266853, PMID 34388007, PMID 34903471, PMID 34919827, PMID 34981300, PMID 35157829, PMID 35443673, PMID 35701060, PMID 36241128, PMID 36283797, PMID 36541117, PMID 36610886, PMID 36635680, PMID 36701184, PMID 36845633
2009 (3), 2018 (3), 2015 (1)